JP2012517479A5 - - Google Patents

Download PDF

Info

Publication number
JP2012517479A5
JP2012517479A5 JP2011550244A JP2011550244A JP2012517479A5 JP 2012517479 A5 JP2012517479 A5 JP 2012517479A5 JP 2011550244 A JP2011550244 A JP 2011550244A JP 2011550244 A JP2011550244 A JP 2011550244A JP 2012517479 A5 JP2012517479 A5 JP 2012517479A5
Authority
JP
Japan
Prior art keywords
fluorophenyl
methyl
methylethyl
chloro
thio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011550244A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012517479A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/023981 external-priority patent/WO2010093845A1/en
Publication of JP2012517479A publication Critical patent/JP2012517479A/ja
Publication of JP2012517479A5 publication Critical patent/JP2012517479A5/ja
Pending legal-status Critical Current

Links

JP2011550244A 2009-02-12 2010-02-12 糖尿病および肥満の処置においてtgr5アゴニストとして使用するためのトリアゾールおよびイミダゾール誘導体 Pending JP2012517479A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US15216309P 2009-02-12 2009-02-12
US61/152,163 2009-02-12
US28413909P 2009-12-11 2009-12-11
US61/284,139 2009-12-11
PCT/US2010/023981 WO2010093845A1 (en) 2009-02-12 2010-02-12 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014174935A Division JP2014240421A (ja) 2009-02-12 2014-08-29 糖尿病および肥満の処置においてtgr5アゴニストとして使用するためのトリアゾールおよびイミダゾール誘導体

Publications (2)

Publication Number Publication Date
JP2012517479A JP2012517479A (ja) 2012-08-02
JP2012517479A5 true JP2012517479A5 (enExample) 2013-01-31

Family

ID=42102146

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011550244A Pending JP2012517479A (ja) 2009-02-12 2010-02-12 糖尿病および肥満の処置においてtgr5アゴニストとして使用するためのトリアゾールおよびイミダゾール誘導体
JP2014174935A Pending JP2014240421A (ja) 2009-02-12 2014-08-29 糖尿病および肥満の処置においてtgr5アゴニストとして使用するためのトリアゾールおよびイミダゾール誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014174935A Pending JP2014240421A (ja) 2009-02-12 2014-08-29 糖尿病および肥満の処置においてtgr5アゴニストとして使用するためのトリアゾールおよびイミダゾール誘導体

Country Status (8)

Country Link
US (1) US8785488B2 (enExample)
EP (1) EP2396304A1 (enExample)
JP (2) JP2012517479A (enExample)
KR (1) KR20110119790A (enExample)
CN (1) CN102395567A (enExample)
AR (1) AR075255A1 (enExample)
TW (1) TW201040168A (enExample)
WO (1) WO2010093845A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
US8846739B2 (en) 2009-12-11 2014-09-30 Exelixis Patent Company Llc TGR5 agonists
WO2011133595A1 (en) 2010-04-19 2011-10-27 Massachusetts Institute Of Technology A polymer-nanostructure composition for selective molecular recognition
EA201270778A1 (ru) 2010-05-06 2013-04-30 Бристол-Майерс Сквибб Компани Бициклические гетероарильные аналоги в качестве модуляторов рецептора gpr119
KR20130099268A (ko) * 2010-09-29 2013-09-05 이 아이 듀폰 디 네모아 앤드 캄파니 살진균제 이미다졸
WO2012082947A1 (en) * 2010-12-16 2012-06-21 Irm Llc Compounds and compositions as tgr5 agonists
WO2012109646A1 (en) 2011-02-11 2012-08-16 Vertex Pharmaceuticals Incorporated Treatment of hcv in hiv infection patients
JP2014518853A (ja) 2011-04-28 2014-08-07 ブリストル−マイヤーズ スクイブ カンパニー 新規な二環式窒素含有ヘテロアリールtgr5受容体調節因子
US8703776B2 (en) * 2011-06-15 2014-04-22 Cymabay Therapeutics, Inc. Agonists of GPR131 and uses thereof
WO2013054338A1 (en) * 2011-07-06 2013-04-18 Cadila Healthcare Limited 2-thio-imidazole derivatives as tgr5 modulators
US9593109B2 (en) 2011-08-26 2017-03-14 Cymabay Therapeutics, Inc. Bicyclic agonists of GPR131 and uses thereof
WO2013062887A1 (en) * 2011-10-26 2013-05-02 Merck Sharp & Dohme Corp. Substituted pyridine derivatives useful as gpr131 agonists
WO2013102929A1 (en) 2011-12-26 2013-07-11 Cadila Healthcare Limited Novel compounds for treatment of diabetes, obesity or related disorders
WO2013164838A1 (en) * 2012-03-07 2013-11-07 Cadila Healthcare Limited Heterocyclic compounds and their use for treatment of diabetes, obesity or related disorders
LT6064B (lt) 2012-10-15 2014-08-25 Vilniaus Universitetas Fluorinti benzensulfonamidai kaip karboanhidrazės inhibitoriai
CN103864754B (zh) * 2012-12-10 2016-12-21 中国科学院上海药物研究所 五元唑类杂环化合物及其制备方法、药物组合物和用途
WO2014100021A1 (en) * 2012-12-17 2014-06-26 Exelixis, Inc. Tgr5 agonists: imidazole and triazole compounds containing a quaternary nitrogen
WO2014100025A1 (en) * 2012-12-17 2014-06-26 Exelixis, Inc. Tgr5 agonists having an imidazole or triazole core with subtituent having a quaternary nitrogen
CN103755652B (zh) * 2013-12-20 2015-08-05 陕西理工学院 一种磺酰胺类化合物及其应用
EP3154634B1 (en) * 2014-06-12 2021-02-24 Université de Lille Imidazol- or 1,2,4-triazol-derivatives and their use
US10208081B2 (en) * 2014-11-26 2019-02-19 Enanta Pharmaceuticals, Inc. Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
NZ735126A (en) 2015-03-31 2022-10-28 Enanta Pharm Inc Bile acid derivatives as fxr/tgr5 agonists and methods of use thereof
CN105001171A (zh) * 2015-07-13 2015-10-28 佛山市赛维斯医药科技有限公司 一类硝基苯三氮唑亚砜类11β-HSD1抑制剂及其用途
CN104987313A (zh) * 2015-07-13 2015-10-21 佛山市赛维斯医药科技有限公司 一类末端取代的三氮唑亚砜类化合物、其制备方法及其用途
CN105017170A (zh) * 2015-07-13 2015-11-04 佛山市赛维斯医药科技有限公司 一类腈基苯三氮唑亚砜类11β-HSD1抑制剂及其用途
CN104987312A (zh) * 2015-07-13 2015-10-21 佛山市赛维斯医药科技有限公司 一类胺基苯三氮唑亚砜类11β-HSD1抑制剂及其用途
WO2017042380A1 (en) * 2015-09-11 2017-03-16 Universite De Lille 2 Droit Et Sante Novel 5-amino-2-thioimidazole compounds and their use
EP3210469A1 (de) 2016-02-23 2017-08-30 Bayer Cropscience AG Verwendung von substituierten thio-1,2,4-triazolen zur steigerung der stresstoleranz in pflanzen
US11236055B2 (en) 2016-07-01 2022-02-01 Venenum Biodesign, LLC Non-systemic TGR5 agonists
CN106432222A (zh) * 2016-09-19 2017-02-22 丹诺医药(苏州)有限公司 8‑氯‑1‑环丙基‑7‑氟‑9‑甲基‑4‑氧‑4‑氢‑喹嗪‑3‑羧酸酯及其制备方法
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
CN111039880B (zh) * 2019-12-10 2022-06-21 河南大学 咪康唑及其衍生物作为tgr5激动剂的应用
TW202140440A (zh) 2020-02-28 2021-11-01 美商克力歐普股份有限公司 Gpr40激動劑
AU2021275038A1 (en) 2020-05-19 2022-12-22 Kallyope, Inc. AMPK activators
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators
CN111763173B (zh) * 2020-07-14 2022-11-01 河南大学 苯乙基咪唑类衍生物及其用途
EP4377297A4 (en) * 2021-07-30 2025-05-28 The Regents of the University of California Compounds for modulating epithelial 15-(s)-lipoxygenase-2 and methods of use for same
US12221423B1 (en) 2023-10-23 2025-02-11 King Faisal University 3-(3-fluorophenyl)-5-(4-methoxybenzylthio)-4-phenyl-4H-1,2,4-triazole as an antimicrobial compound
WO2025162115A1 (zh) * 2024-02-04 2025-08-07 成都麻沸散医药科技有限公司 一种杂环化合物及其制药用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL272996A (enExample) * 1960-12-28
JPS61148176A (ja) * 1984-12-21 1986-07-05 Ota Seiyaku Kk 新規複素環式化合物
EP0786455B1 (en) 1994-09-26 2003-12-03 Shionogi & Co., Ltd. Imidazole derivative
AU2002361345B8 (en) * 2001-11-28 2008-06-26 Ipsen Pharma S.A.S. 5-sulphanyl-4H-1,2,4-triazole derivatives and their use as medicine
AR040241A1 (es) 2002-06-10 2005-03-23 Merck & Co Inc Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
EP1615637A1 (en) 2003-04-11 2006-01-18 Novo Nordisk A/S Pharmaceutical use of substituted 1,2,4-triazoles
EP1635832A2 (en) * 2003-06-06 2006-03-22 Merck & Co., Inc. Combination therapy for the treatment of diabetes
JP2007509959A (ja) * 2003-10-28 2007-04-19 アムゲン インコーポレイティッド トリアゾール化合物およびそれに関連する使用法
JP2005170939A (ja) * 2003-11-20 2005-06-30 Takeda Chem Ind Ltd 糖尿病の予防・治療剤
CA2558224A1 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
JP2006063064A (ja) 2004-07-27 2006-03-09 Takeda Chem Ind Ltd 受容体作動剤
WO2006068199A1 (ja) 2004-12-22 2006-06-29 Mochida Pharmaceutical Co., Ltd. 代謝的に安定な3-オキシ-1,2,4-トリアゾール誘導体
JPWO2006080533A1 (ja) * 2005-01-31 2008-06-19 持田製薬株式会社 3−アミノ−1,2,4−トリアゾール誘導体
SG159528A1 (en) 2005-02-04 2010-03-30 Senomyx Inc Compounds comprising linked hetero aryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions
WO2007021941A2 (en) 2005-08-16 2007-02-22 Icagen, Inc. Inhibitors of voltage-gated sodium channels
EP1988083B1 (en) 2006-02-03 2014-04-02 Taisho Pharmaceutical Co., Ltd. Triazole derivative
JP2007210974A (ja) * 2006-02-13 2007-08-23 Sankyo Co Ltd 置換されたウレア化合物を含有する医薬
JP2009537564A (ja) 2006-05-17 2009-10-29 インサイト・コーポレイション 11−βヒドロキシルステロイドデヒドロゲナーゼタイプIの複素環阻害剤およびそれを用いる方法

Similar Documents

Publication Publication Date Title
JP2012517479A5 (enExample)
JP2014240421A (ja) 糖尿病および肥満の処置においてtgr5アゴニストとして使用するためのトリアゾールおよびイミダゾール誘導体
JP2013513605A5 (enExample)
RU2455288C2 (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2016526561A5 (enExample)
JP2006518763A5 (enExample)
RU2009147733A (ru) Пиридилпиперидновые антагонисты рецептора орексинов
JP2010513272A5 (enExample)
JP2014532640A5 (enExample)
JP2012528847A5 (enExample)
JP2013513605A (ja) Tgr5アゴニスト
JP2013507449A5 (enExample)
JP2007523181A5 (enExample)
JP2005511543A5 (enExample)
RU2008144571A (ru) Пиридиламидные антагонисты кальциевых каналов т-типа
JP2007308471A5 (enExample)
RU2021133444A (ru) Производные бензимидазола в качестве модуляторов ror-гамма
RU2014121984A (ru) Бензолсульфонамидные соединения и их применение в качестве терапевтических средств
JP2007530690A5 (enExample)
JP2015172062A5 (enExample)
EA017696B1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
SI2513053T1 (en) Pyrrolidine carboxylic acid derivatives as G-protein-coupled receptor 43 agonists (GPR43), pharmaceutical composition and methods for use in the treatment of metabolic disorders
RU2009125620A (ru) Органические соединения
JP2011523633A5 (enExample)
JP2013507366A5 (enExample)